The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $49.62 in the prior trading day, PTC Therapeutics Inc (NASDAQ: PTCT) closed at $48.89, down -1.47%. In other words, the price has decreased by -$1.47 from its previous closing price. On the day, 1.03 million shares were traded. PTCT stock price reached its highest trading level at $49.435 during the session, while it also had its lowest trading level at $48.18.
Ratios:
Our goal is to gain a better understanding of PTCT by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.91 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.59. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 3.89.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on June 17, 2025, initiated with a Buy rating and assigned the stock a target price of $80.
On May 09, 2025, BofA Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $68.
Citigroup Upgraded its Sell to Neutral on May 07, 2025, while the target price for the stock was maintained at $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 15 ’25 when Boulding Mark Elliott sold 1,929 shares for $46.18 per share. The transaction valued at 89,081 led to the insider holds 103,901 shares of the business.
Boulding Mark Elliott sold 883 shares of PTCT for $40,636 on May 16 ’25. The EXEC. VP AND CLO now owns 103,901 shares after completing the transaction at $46.02 per share. On May 16 ’25, another insider, Boulding Mark Elliott, who serves as the Officer of the company, bought 883 shares for $46.02 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTCT now has a Market Capitalization of 3932731136 and an Enterprise Value of 4325135872. As of this moment, PTC’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.19. Its current Enterprise Value per Revenue stands at 2.44 whereas that against EBITDA is 4.828.
Stock Price History:
The Beta on a monthly basis for PTCT is 0.51, which has changed by 0.41055977 over the last 52 weeks, in comparison to a change of 0.111126065 over the same period for the S&P500. Over the past 52 weeks, PTCT has reached a high of $58.38, while it has fallen to a 52-week low of $28.72. The 50-Day Moving Average of the stock is 1.79%, while the 200-Day Moving Average is calculated to be 7.20%.
Shares Statistics:
The stock has traded on average 1.29M shares per day over the past 3-months and 1205230 shares per day over the last 10 days, according to various share statistics. A total of 79.23M shares are outstanding, with a floating share count of 77.14M. Insiders hold about 2.67% of the company’s shares, while institutions hold 98.44% stake in the company. Shares short for PTCT as of 1748563200 were 4751620 with a Short Ratio of 3.68, compared to 1745971200 on 5006670. Therefore, it implies a Short% of Shares Outstanding of 4751620 and a Short% of Float of 6.890000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
